Equillium, Inc.

NASDAQ:EQ

Biotechnology

Healthcare
$1.10 +1.51%

+$0.05 today

Market cap
$90.56M
Beta
1.76
P/E (TTM)
-15.3
EPS (TTM)
-$0.20
52W Low $0.27High $3.45

Volume 0.89M

Average 0.60M

EQ Minority Interest

The portion of consolidated subsidiaries' equity owned by outside shareholders.

Equillium, Inc.NASDAQ: EQ

Minority Interest · Q1 FY2026 · quarter ended Mar 2026

Minority interest remains negative

Q1 FY2026 minority interest was $0, compared with $0 a year earlier.

Context

  • Minority interest amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Minority interest increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Minority Interest past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Minority Interest history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Minority Interest vs competitors

How EQ compares with its peers on the latest reported figures

  • EQ's Mar 2026 minority interest of $0 is the 3rd highest of the 10 companies compared; the peer median is $0.
  • Minority interest amounts to 0.0% of total assets for EQ, versus a peer median of 0.0%.
EQ Competitors Peer median
Minority Interest for EQ and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
FBIOFortress Biotech, Inc.Mar 2026$40.17M +292.4%+14.0%11.3%
COEPCoeptis Therapeutics, Inc.Mar 2026$401.89K -59.2%—2.0%
EQEquillium, Inc.Mar 2026$0 ——0.0%
IPSCCentury Therapeutics, Inc.Mar 2026$0 ——0.0%
SPRBSpruce Biosciences, Inc.Mar 2026$0 ——0.0%
CUECue Biopharma, Inc.Mar 2026$0 ——0.0%
OTLKOutlook Therapeutics, Inc.Mar 2026$0 ——0.0%
NRXPNRx Pharmaceuticals, Inc.Mar 2026$0 ——0.0%
TELOTelomir Pharmaceuticals, Inc. Common StockMar 2026$0 ——0.0%
OSTXOS Therapies IncorporatedMar 2026$0 ——0.0%
Peer median (excluding EQ) $0+116.6%+14.0%0.0%

Competitors are the stored peer set for EQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents50.37M59.11M23.22M18.09M30.28M
Short-term Investments30.35M11.92M17.65M4.49M0
Net Receivables04.11M6.29M1.14M108K
Inventory00000
Other Current Assets08K235K429K(547K)
Total Current Assets83.37M76.74M49.35M24.98M30.28M
Property, Plant & Equipment (Net)1.88M1.58M1.11M626K658K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets153K104K70K00
Total Non-current Assets2.04M1.69M1.18M626K658K
Total Assets85.41M78.42M50.53M25.6M31.89M
Account Payables1.23M3.98M4.71M2.68M755K
Short-term Debt1.43M5.71M0197K363K
Tax Payables000365K0
Deferred Revenue014.7M15.73M00
Other Current Liabilities3.38M03.64M2.68M1.82M
Total Current Liabilities8.92M32.04M27.57M6.36M2.93M
Long-term Debt8.75M3.24M00356K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)010.38M000
Other Non-current Liabilities00000
Total Non-current Liabilities9.99M14.44M384K187K356K
Total Liabilities18.9M46.48M27.96M6.54M3.29M
Common Stock2K3K3K3K5K
Retained Earnings(109.98M)(172.41M)(185.74M)(193.81M)(216.21M)
Accumulated OCI(138K)76K140K781K363K
Other Stockholders Equity00000
Minority Interest00000
Total Equity66.51M31.94M22.57M19.06M28.6M
Total Debt11.79M10.19M824K384K719K
Net Debt(38.58M)(48.92M)(22.39M)(17.7M)(29.56M)

Equillium, Inc.

NASDAQ:EQ

Intrinsic Alpha fair value

Locked

Current Price

$1.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.